D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 15 380 KRW 0.92% Market Closed
Market Cap: 683.8B KRW

Dongkook Pharmaceutical Co Ltd's latest stock split occurred on Sep 10, 2020

The company executed a 5-for-1 stock split, meaning that for every share held, investors received 5 new shares.

Before the split, Dongkook Pharmaceutical Co Ltd traded at 151100.0023 per share. Afterward, the share price was about 30636.2396.

The adjusted shares began trading on Sep 10, 2020. This was Dongkook Pharmaceutical Co Ltd's 2nd stock split, following the previous one in Jun 25, 2009.

Last Splits:
Sep 10, 2020
5-for-1
Jun 25, 2009
93773-for-72133
Pre-Split Price
29 484.9419 151 100.0023
Post-Split Price
30 636.2396
Before
After
Last Splits:
Sep 10, 2020
5-for-1
Jun 25, 2009
93773-for-72133

Dongkook Pharmaceutical Co Ltd
Stock Splits History

Dongkook Pharmaceutical Co Ltd Stock Splits Timeline
Sep 10, 2020
Sep 10, 2020
Split 5-for-1
x5
Pre-Split Price
29 484.9419 151 100.0023
Post-Split Price
30 636.2396
Before
After
Jun 25, 2009
Jun 25, 2009
Split 93773-for-72133
x1.300001386328
Pre-Split Price
N/A
Post-Split Price
2 435.4626
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 29, 2025
Capita PLC
LSE:CPI
1-for-15
/15
12.74 12.74 GBX N/A
Apr 29, 2025
Capita PLC
XMUN:CTAA
1-for-15
/15
0.1502 0.1502 EUR N/A
Apr 29, 2025
S
Scan Inter PCL
SET:SCN
1-for-1
x1
0.42 0.42 THB 0.43 0.43 THB
Apr 29, 2025
S
Shaanxi Meineng Clean Energy Corp Ltd
SZSE:001299
1-for-1
x1
14.8 10.5846 CNY 10.63 10.63 CNY
Apr 29, 2025
F
Foxo Technologies Inc
AMEX:FOXO
1-for-10
/10
0.0084 0.0841 USD N/A
Load More

Dongkook Pharmaceutical Co Ltd
Glance View

Market Cap
676.2B KRW
Industry
Pharmaceuticals

DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2007-05-29. The firm develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. The company also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The firm distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.

Intrinsic Value
21 381.27 KRW
Undervaluation 28%
Intrinsic Value
Price
D
Back to Top